{"date": "2021-12-07 14:29:56.776000+00:00", "ticker": "ABDN", "mrkt_info": {"open": 237.0, "close": 242.6}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-lead\">\n<p>RNS Number : 8682UAberdeen Standard Asia Focus PLC07 December 2021</p>\n</div>\n<div class=\"tr-npp-body\">\n<p>\n<span>Aberdeen Standard Asia Focus PLC (the \"Company\")</span>\n</p>\n<p>\n<span>Legal Entity Identifier (LEI):</span>\n<span>5493000FBZP1J92OQY70</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>Conversion of Convertible Unsecured Loan Stock 2025 (\"CULS\")</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>7 December 2021</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>Application is being made by the Company to the</span>\n<span>UK Listing Authority and the London Stock Exchange Plc <span>for a total of 935 new Ordinary shares of 25p each (\"Ordinary Shares\") to be admitted to the Official List, and dealings are expected to commence on or around 14 December 2021. The new Ordinary Shares will rank pari passu with the existing Ordinary shares of the Company.</span>\n</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>The listing application has been made following the conversion of \u00a313,764 units of CULS in the period to 30 November 2021.</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>Enquiries:</span>\n</p>\n<p>\n<span>Charles Mearns</span>\n</p>\n<p>\n<span>Aberdeen Asset Management PLC</span>\n</p>\n<p>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact <a href=\"mailto:rns@lseg.com\" data-type=\"email\" translate=\"no\">rns@lseg.com</a> or visit <a href=\"http://www.rns.com/\" data-type=\"url\" class=\"tr-link\" translate=\"no\">www.rns.com</a> .RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our <a href=\"https://www.lseg.com/privacy-and-cookie-policy\" data-type=\"url\" class=\"tr-link\" translate=\"no\">Privacy Policy</a> .END</p>\n<p>MSCUPGAGPUPGGCM</p>\n</div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2021 Thomson Reuters Limited.</p></div>"}